Deals & business · first seen yesterday, updated yesterday
ERS Genomics and Sai Life Sciences sign CRISPR/Cas9 license agreement
ERS Genomics Limited (‘ERS’), the CRISPR licensing company, announced that it has signed a non-exclusive license agreement with Sai Life Sciences , an integrated contract research, development, and manufacturing organization (CRDMO). The ag…
Summary from Express Pharma.